Antibody-induced demyelination is an important component of pathology in multiple sclerosis. In particular, antibodies to myelin oligodendrocyte glycoprotein (MOG) are elevated in multiple sclerosis patients, and they have been implicated as mediators of demyelination. We have shown previously that antibody crosslinking of MOG in oligodendrocytes results in the repartitioning of MOG into glycosphingolipid-cholesterol membrane microdomains ("lipid rafts"), followed by changes in the phosphorylation of specific proteins, including dephosphorylation of ␤-tubulin and the ␤ subunit of the trimeric G protein and culminating in rapid and dramatic morphological alterations. In order to further elucidate the mechanism of anti-MOG-mediated demyelination, we have carried out a proteomic analysis to identify the set of proteins for which the phosphorylation states or expression levels are altered upon anti-MOG treatment. We demonstrate that treatment of oligodendrocytes with anti-MOG alone leads to an increase in calcium influx and activation of the MAPK/Akt pathways that is independent of MOG repartitioning. However, further cross-linking of anti-MOG⅐MOG complexes with a secondary anti-IgG results in the lipid raft-dependent phosphorylation of specific proteins related to cellular stress response and cytoskeletal stability. Oligodendrocyte survival is not compromised by these treatments. We discuss the possible significance of the anti-MOG-induced signaling cascade in relation to the initial steps of MOG-mediated demyelination.
The investigation of the transfer of information between myelin and axons is at the forefront of myelin biology and demyelinating disease (1) (2) (3) . Loss or damage of myelin, such as occurs in the human demyelinating disease multiple sclerosis, results in axonal degeneration with severe, generally irreversible, functional consequences (4) . Multiple sclerosis-related demyelination is in part induced by antibodies directed against surface antigens of myelin and oligodendrocytes (OLs), 1 the myelin-producing cells of the central nervous system (5) . In particular, antibodies to myelin oligodendrocyte glycoprotein (MOG), a highly encephalitogenic glycoprotein concentrated in the outer lamella of the myelin sheath and thus exposed to the environment (6) , have been implicated as mediators of demyelination (7) (8) (9) (10) .
Upon ligand or antibody cross-linking, a variety of plasma membrane receptors undergo enhanced partitioning into glycosphingolipid-cholesterol membrane microdomains ("lipid rafts") as an obligatory first step toward participation in early signal transduction events (11) (12) (13) . We have previously shown that antibody cross-linking of MOG on the surface of OLs results in the rapid repartitioning of a significant fraction of MOG into lipid rafts, followed by dephosphorylation of ␤-tubulin and the ␤ subunit of the trimeric G protein (G␤), and a rapid retraction of OL processes and myelin-like membranes (14) . In order to elucidate this mechanism and better consider its relationship to antibody-mediated demyelination in multiple sclerosis, we have taken a proteomic approach to identify target proteins for which the phosphorylation states and/or expression levels are altered upon MOG cross-linking. We show that antibody-induced activation of MOG signaling in its non-lipid raft state triggers the activation of MAPK and Akt pathways and an increase in calcium influx. Further cross-linking of anti-MOG⅐MOG complexes by anti-IgG leads to a requisite MOG repartitioning into lipid rafts, followed by the activation of signaling pathways related to stress response and cytoskeletal instability and finally dramatic changes in cellular morphology. These processes are reversible and, at least in the short run, nontoxic. We propose that the signaling cascade triggered upon antibody-mediated repartitioning of MOG into lipid rafts is pertinent to the initial steps of MOG-mediated demyelination in multiple sclerosis.
-␤-tubulin, -acetylated and -tyrosine tubulin, and -heme oxygenase-1 (HSP32) (Sigma); anti-phosphoserine and -phosphothreonine (Zymed Laboratories Inc., San Francisco, CA); anti-annexin vi and -phosphotyrosine (4G10) and goat anti-mouse IgG (Transduction Laboratories, San Diego, CA); phospho-Akt, phospho-EF-2, and phospho-ErbB2 antibody sampler kit (Cell Signaling Technology, Beverly, MA); anti-insulin growth factor-1 receptor, -Src pY418, and -pY529 phosphospecific antibodies (BIOSOURCE, Camarillo, CA); anti-HSP74/Grp75 (Calbiochem); anti-active MAPK and -pan-Erk1/2 (Promega, Madison, WI); anti-myelin basic protein (MBP) (Sternberger Monoclonals, Baltimore, MD). O4 monoclonal antibody (15) was prepared in our laboratory (16) .
Cell Culture-Mixed primary cultures and highly enriched populations of maturing OLs were prepared as described previously (17, 18) . OL populations were grown in defined medium modified N2 (19, 20) for 7 days to obtain MOG-expressing OLs.
Antibody Perturbation-OLs were first incubated at 37°C with monoclonal anti-MOG antibody (155 g/ml IgG) for various time intervals (5-60 min). Antibody was then washed out by two changes of Dulbecco's modified Eagle's medium. In most cases, the OLs were then further incubated at 37°C with goat anti-mouse IgG (1:500) for 5-60 min to cross-link the anti-MOG⅐MOG complexes formed in the first step. In some cases, cells were treated prior to antibody incubation with the protein kinase inhibitors (Calbiochem) PD098059 (50 M), LY294002 (50 M), or Y27632 (15 M) for 2 h or with methyl-␤-cyclodextrin (MCD, 5 mM; Sigma) for 15 min at 37°C. Controls were subjected to the same schedule of washes and incubations.
Detergent Extraction and Sucrose Gradient UltracentrifugationCells were scraped into 0.5 ml of a solution of 150 mM NaCl, 5 mM EDTA, 25 mM Tris-Cl buffer (pH 7.5) containing 1 mM phenylmethylsulfonyl fluoride, 10 g/ml leupeptin/aprotinin, 50 mM NaF, 10 mM NaP 2 O 7 , 1 mM sodium o-vanadate, and Triton X-100 (1% final concentration) as described previously (14) . Samples were centrifuged (13,000 ϫ g, 15 min) to separate them into a detergent-insoluble pellet and a detergent-soluble supernatant fraction and processed for immunoprecipitation and SDS-PAGE. For sucrose gradient ultracentrifugation (14, 21) , pellet fractions were mixed with 2 M sucrose, overlaid with 1 and 0.2 M sucrose, and centrifuged for 16 h at 200,000 ϫ g at 4°C. After centrifugation, 0.5-ml fractions were collected at 4°C from the top (fraction 1) to the bottom (fraction 10) of the gradient.
Immunoprecipitation-Soluble and insoluble fractions of the Triton X-100 extracts were solubilized in 500 l of radioimmunoprecipitation buffer (10 mM Tris, pH 7.6, 150 mM NaCl, 0.1% SDS, 1% deoxycholate, 1% Nonidet P-40, 1% Triton X-100) and incubated overnight with antiFyn (1:50) at 4°C. Protein A-Sepharose (0.01 mg/ml) beads (Amersham Biosciences) were added for 2 h at 4°C. Immunocomplexes were separated by centrifugation, washed four times with radioimmunoprecipitation buffer, and analyzed by SDS-PAGE/Western blot with anti-panFyn or anti-phosphorylated Fyn (anti-pY418 or anti-pY529).
SDS-PAGE and Immunoblotting Analysis-Solubilized samples (described above) were loaded onto acrylamide gels (Protean II minicell apparatus; Bio-Rad). SDS-PAGE was performed as described previously (14) . Densitometric analysis of immunoblots was carried out using NIH Image 1.62.
Two-dimensional PAGE-Two-dimensional PAGE was carried out as described previously (2, 14, 22) . Briefly, OL extracts (300 g of protein) were solubilized in 7 M urea, 2 M thiourea, 2% ASB-14, 0.5% IPG buffer 4 -7, 100 mM dithiothreitol, 0.001% bromphenol blue. Samples were applied to Immobiline TM Dry Strip, pH 4 -7, isoelectric focusing gels (Amersham Biosciences). Proteins were separated in the first dimension (200 V, 1 h; 500 V, 1 h; 1,000 V, 1 h; ramped to 8,000 V, 30 min; held at 8,000 V for 30,000 V-h) at 20°C using an IPGPhor electrophoresis unit (Amersham Biosciences). For the second dimension, SDS-PAGE was carried out in 10% acrylamide running gels.
Mass Spectrometric Analysis-Coomassie Blue-stained spots were excised and digested overnight with trypsin. Tryptic peptides were separated by microcapillary liquid chromatography coupled to a tandem mass spectrometer (LCQ-DECA; Finnigan-MAT, San Jose, CA; Center for Proteomics and Biological Mass Spectrometry at the University of Connecticut Health Center). Peptide fragmentation spectra were analyzed against the OWL data base by using the SEQUEST algorithm followed by INTERACT and PEPTIDE PROPHET (2) .
Immunofluorescence Microscopy-Mature OLs were stained live with anti-sulfatide O4 (16) or fixed with 4% paraformaldehyde and stained with either phosphospecific (1:50) or total EF-2 (1:100) antibodies or with anti-MBP as described previously (14) . The diameter of randomly chosen cells (100 cells/experiment) was determined by using a calibrated microscopic grid.
Detection of Cell Death-Cell death was detected by using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) assay (Apoptag kit; Serologicals Corp., Norcross, GA) according to the manufacturer's instructions and as described before (23) ; the total cell number was determined by Hoechst dye staining. Percentages of TUNELϩ/total cells were estimated by analysis of at least 30 fields from three independent experiments (100 cells were analyzed in each experiment). Determination of cAMP and Calcium (Ca 2ϩ ) Levels-Changes in cAMP levels upon MOG cross-linking were determined by using an enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI) following the manufacturer's instructions. To estimate changes in Ca 2ϩ levels, mature OLs were labeled with 10 g/ml Fluo-4/AM (Molecular Probes, Inc., Eugene, OR) for 30 min at 37°C. After 30 min of recovery with fresh medium, anti-MOG antibody followed by anti-mouse IgG (5-min incubation each antibody at 37°C), anti-MAG antibody followed by anti-mouse IgG (5 min incubation each antibody at 37°C), or antimouse IgG alone (5-min incubation at 37°C) was added to the culture. Fluorescence intensity changes (estimating Ca 2ϩ levels) were recorded every 15 s (starting before the addition of anti-MOG or anti-MAG antibody) by time lapse confocal microscopy (LSM 510 Zeiss) using a thermo-controlled chamber. Image analysis was carried out with NIH Image 1.62. Ionomycin was used as a positive control. A total of 20 cells were analyzed for each condition.
Statistical Analysis-Means and S.E. were calculated, and evaluation of statistical significance between conditions was made using Student's two-tailed t test. (14, 21) that treatment of live OLs with anti-MOG followed by cross-linking secondary antibody (subsequently referred to as MOG cross-linking) causes rapid repartitioning of MOG into a detergent-insoluble fraction. At least half of this fraction has key biochemical characteristics of lipid rafts, including detergent solubility at 37°C or at 4°C upon prior cholesterol perturbation, and low density. MOG repartitioning is followed rapidly by changes in the phosphorylation state of specific proteins and dramatic changes in OL cytoarchitecture. In contrast, treatment with anti-MOG alone was ineffective at inducing MOG repartitioning or changes in cell morphology (14) ; these effects were confirmed in this study, even when treatment with anti-MOG alone was extended to 60 min (Fig. 1A) .
RESULTS

Identification of Proteins
To identify the proteins undergoing MOG cross-linking-mediated changes in phosphorylation state, we first resolved the total population of cellular proteins by two-dimensional PAGE, using a method that allows increased resolution of transmembrane and GPI-anchored proteins from lipid-rich membranes such as myelin and myelin-like membranes from OLs (22) (Fig.  1, B-D) . No changes were observed in the overall pattern of proteins identified by silver staining (Fig. 1B) . However, upon further analysis by anti-phosphoamino acid immunoblots generated from these two-dimensional gels, we found significant differences in the phosphorylation state of specific proteins (Fig. 1C) . These phosphoproteins were then identified by mass spectrometry and/or two-dimensional Western blot with specific antisera (Fig. 1D ). As noted previously (14) , G␤ and ␤-tubulin underwent dephosphorylation on threonine (Fig. 1C , spot 4) or tyrosine (Fig. 1C, spot 5 ), respectively. In addition, eight other proteins were identified (Figs. 1, C and D, and 2A) that underwent hyperphosphorylation of either tyrosine heat shock protein 74 (HSP74; spot 1), annexin vi (spot 2), Fyn (spot 3), mitogen-activated protein kinase (MAPK; spots 6 -6Ј), ␣-enolase (spot 7), threonine collapsin response mediator protein-2 (CRMP-2; spot 8), elongation factor 2 (EF-2; spot 9), and/or serine ␣-enolase (spot 7), CRMP-2 (spot 8), Akt (identified by one-dimensional immunoblot with a phosphospecific antibody; Fig. 2A ). In contrast to MOG, the detergent insolubility of these proteins was not changed upon cross-linking (data not shown). These proteins fall into three general functional categories involving cellular stress response, signal transduction, and cytoskeletal stability.
Response of OLs to Anti-MOG Alone Compared with MOG Cross-linking-Extracellular signal-regulated kinase members of the MAPK kinase family, in close association with phosphatidylinositol 3-kinase and its downstream effector Akt (24), promote OL survival (25, 26) . Further investigation showed that in contrast to the other phosphoproteins that required MOG cross-linking, e.g. EF-2 ( Fig. 2B and data not shown), treatment with anti-MOG antibody alone (i.e. no secondary cross-linking) led to hyperphosphorylation of both MAPK and Akt (Fig. 2B) .
In many cases, an interrelationship has been observed between protein phosphorylation and the intracellular levels of calcium (Ca 2ϩ ) and/or cAMP. For example, G␤ down-regulates Ca 2ϩ influx by modulating the activity of voltage-gated Ca 2ϩ channels (27) ; increased Ca 2ϩ levels lead to the phosphorylation of certain proteins, including MAPK (28 -30); and calciumcalmodulin kinase III phosphorylates EF-2 in response to both Ca 2ϩ and cAMP (31) . Therefore, we examined Ca 2ϩ and cAMP levels before and after exposure of OLs to antibodies. Calcium levels rapidly increased (Յ1 min) upon treatment with anti-MOG alone; they remained elevated without further increase, even after the addition of secondary cross-linking antibody (starting at 300 s, see arrow; Fig. 3A ). As controls, this response was not observed when cross-linking was carried out using anti-myelin-associated glycoprotein (anti-MAG) antibody or secondary antibody alone (Fig. 3A) . In contrast, the levels of cAMP in OLs were unchanged by treatment with either anti-MOG antibody alone, anti-MOG followed by secondary antibody, or secondary antibody alone (Fig. 3B) .
We conclude that treatment with anti-MOG antibody alone is sufficient to cause increased Ca 2ϩ levels and hyperphosphorylation of MAPK and Akt.
Changes in Stress Response-related Proteins upon MOG Cross-linking-The cellular stress response (e.g. heat shock) is a protective mechanism that enhances cell survival in times of environmental stress by down-regulating the level of protein synthesis, thereby limiting the accumulation of misfolded proteins (32). The MOG cross-linking-dependent hyperphosphorylations of EF-2, HSP74, and ␣-enolase (another heat shock protein) (29) are consistent with a cellular stress response. In addition, the level of HSC70, a member of the HSP70 family previously implicated in multiple sclerosis (33) , was also significantly increased upon MOG cross-linking, whereas the total levels of two other heat shock proteins, HSP90 and HSP32, were unaffected (Fig. 4A) . Since EF-2 is inactivated by phosphorylation at residue Thr 56 , thereby preventing the elongation step of protein synthesis (31), we used an antibody directed against phospho-EF-2/Thr 56 to further study this protein in OLs. We found that EF-2 did in fact undergo hyperphosphorylation at Thr 56 upon MOG cross-linking and that this occurred (5), MAPK (6 -6Ј), ␣-enolase (7), CRMP-2 (8), and EF-2 (9) . Note that the number of spots in D is higher than in C due to the existence of multiple protein isoforms, not all of which are phosphorylated. The asterisks indicate phosphospots. ␣-Enolase is phosphorylated on both tyrosine and serine, and CRMP-2 is phosphorylated on both serine and threonine residues. Typical results of three independent experiments are shown. in the Triton X-100-soluble fraction; as shown also in Fig. 1B , the total level of EF-2 was unmodified (Fig. 4A) . Immunocytochemistry further confirmed the cross-linking-dependent hyperphosphorylation of EF-2 in OLs, accompanied by the predicted retraction of OL processes (Fig. 4B, d) .
The changes in stress-responding proteins and OL morphology could in principle be an indication of cell death. However, the number of TUNELϩ cells was unchanged even when cells were cross-linked for either up to 2 h and analyzed immediately or for 30 min and then analyzed 2-14 h after antibody removal (Supplementary Fig. 1 ). Similar results were obtained when cell death was evaluated by propidium iodine staining (not shown). We conclude that antibody crosslinking of OLs in culture does not lead to cell death over the time periods studied, and in fact previous studies have shown that the physiological changes induced by MOG cross-linking are reversible (14) .
Role of Cytoskeletal-related Proteins in MOG-mediated Events-The cytoskeleton is a critical mediator of cellular physiology. Several proteins that change their phosphorylation state upon MOG cross-linking (Fig. 1) regulate cytoskeletal dynamics. CRMP-2 activation is related to depolymerization of both actin microfilaments and microtubules (34, 35) ; changes in ␤-tubulin and Fyn phosphorylation affect microtubule integrity (36 -38) ; and annexin vi phosphorylation increases its calcium binding affinity (39) , leading to an inhibition of F-actin polymerization (30) .
Noting that the phosphorylation of CRMP-2 by active Rho serine/threonine kinase leads to actin depolymerization during growth cone collapse (35), we studied the effect of exposing OLs to a Rho kinase inhibitor (Y27632) (40) prior to MOG crosslinking (Fig. 5) . As expected, this treatment prevented the increased phosphorylation of CRMP-2 upon cross-linking (Fig.  5A) and, in addition, significantly attenuated, but did not completely eliminate, the MOG cross-linking-mediated retraction of OL processes (Fig. 5, B, b and f, and C, b and f) . The Rho kinase inhibitor did not prevent changes in either the phosphorylation state of MAPK or Akt (Fig. 5D ) or of the other proteins whose phosphorylation state was altered by MOG cross-linking (data not shown). These data indicate that although Rho kinase is clearly an important mediator of the MOG cross-linkingmediated changes in OL morphology, presumably operating through CRMP-2, other molecules unaffected by the Rho kinase inhibitor also must contribute to this process. Further, although pretreatment of OLs with inhibitors of either MAPK (PD098059) or phosphatidylinositol 3-kinase (LY294002) prior to MOG cross-linking eliminated the increased phosphorylation of MAPK and Akt, respectively (Fig. 5D) , it did not prevent changes in OL morphology (Fig. 5, B, c, d, g, and h, and C, c, d , g, and h).
Tyrosine phosphorylation of ␤-tubulin is stimulated by activation (i.e. phosphorylation) of insulin growth factor receptor and epidermal growth factor receptor (a member of the Erb family of receptor tyrosine kinases) and by Src kinases such as Fyn (37) . Although the expression of epidermal growth factor receptor is down-regulated in OLs upon terminal differentiation, in mature OLs, high levels of ErbB2 tyrosine kinase are maintained (41) , and ErbB2 is necessary for normal OL differentiation and survival; further, the astrocytic expression of ErbB2 is reduced in multiple sclerosis lesions (42) . However, the examination of the effect of MOG cross-linking on these receptors showed that neither insulin growth factor receptor nor ErbB2 phosphorylation was altered (Fig. 6A) .
Although Fyn became hyperphosphorylated upon MOG cross-linking (Fig. 1B) , its reactivity with anti-PY418 (indicating kinase activity) was reduced in the detergent-insoluble fraction (Fig. 6A) . We hypothesized that the overall hyperphosphorylation of Fyn could be due to Csk-mediated phosphorylation of the carboxyl-terminus of Fyn (PY529), a reaction that blocks Fyn kinase activity (43) . Consistent with this hypothesis, we found that upon MOG cross-linking, there is an increased reactivity in the detergent-insoluble fraction against PY529 on Fyn (Fig. 6A) . These data suggest that since Fyn kinase can phosphorylate ␤-tubulin, inactivation of Fyn by MOG cross-linking could lead to ␤-tubulin dephosphorylation, in turn affecting the integrity of microtubules.
Microtubule depolymerization is also triggered by the addition of a carboxyl-terminal tyrosine or deacetylation of ␣-tubulin (37). However, the levels of either acetylated or tyrosinated ␣-tubulin were not changed upon MOG crosslinking (Fig. 6B) .
These results suggest that a rearrangement and depolymerization of the cytoskeleton is an early event following MOG cross-linking, consistent with the observed morphological alterations.
Lipid Rafts Are Mediators of the Signaling Response to MOG Cross-linking-We previously showed that upon MOG crosslinking, the detergent-insoluble MOG is distributed between a low density lipid raft fraction and a higher density fraction that is likely to be based on protein-protein interactions (14) . In order to further assess the importance of the low density fraction in the response of OLs to MOG cross-linking, we disrupted lipid raft integrity by treatment with MCD, an oligomer that depletes cholesterol from the plasma membrane (11) . Under these conditions, GM1 ganglioside (a widely used marker for lipid rafts) was solubilized (1% Triton X-100, 4°C), the low density fraction of MOG was eliminated, and the detergentinsoluble MOG was associated entirely with the high density fraction (Fig. 7A) . Further, this pretreatment with MCD prevented the MOG cross-linking-induced changes in the phosphorylation states of not only ␤-tubulin, G␤, and Fyn, proteins that
FIG. 3. Levels of second messengers upon MOG cross-linking.
A, changes in calcium levels were monitored every 15 s upon treatment with anti-MOG alone (0 -300 s) followed by the subsequent addition of secondary antibody (300 -600 s). The arrow indicates the time of the addition of secondary antibody. Similar treatment was carried out with anti-MAG followed by cross-linking with secondary antibody or with secondary antibody alone. Levels of calcium increase upon treatment with anti-MOG alone but not further after the addition of secondary antibody. MAG cross-linking or treatment with secondary antibody alone does not modify calcium compared with basal levels (1.00). The graph shows the means of the ratio changes (magnitude of fluorescence increase in arbitrary units) of four independent experiments (mean Ϯ S.E.). B, similar levels of cAMP are found in OLs treated with secondary antibody (5 min) alone, anti-MOG antibody (5 min) alone, or anti-MOG (5 min) followed by secondary antibody (5 min). The graph shows the results of three independent experiments (mean Ϯ S.E.).
FIG. 4. MOG cross-linking induces changes in stress responserelated proteins.
A, immunoblot analyses of Triton X-100-soluble (1%, 4°C) (S) and -insoluble (P) fractions upon MOG cross-linking (anti-MOG for 15 min, followed by secondary antibody for 15 min at 37°C; anti-MOGϩ2°Ab) using a phosphoprotein-specific antibody show the hyperphosphorylation of EF-2 (levels of total EF-2 are not modified) and increased total levels of HSC70 but not of HSP90 or HSP32 (levels of actin are used as loading controls). The graph shows ratios in arbitrary units (mean Ϯ S. reside within lipid rafts (14, 44 -46) , but also of the non-lipid raft-associated proteins EF-2, annexin vi, HSP74, and ␣-enolase, and the expression level of HSC70 (Fig. 7B) . In addition, the MOG cross-linking-mediated retraction of OL processes was prevented by MDC pretreatment, i.e. the cell diameters (estimated by MBP immunofluorescent microscopy; mean Ϯ S.E. in arbitrary units) of MOG cross-linked OLs after MCD treatment was significantly larger (5.29 Ϯ 0.22) than those without MCD pretreatment (2.56 Ϯ 0.12) and similar to untreated (5.56 Ϯ 0.23) (Fig. 7C, a-d) . Offering a convenient control, we found that the anti-MOG-induced increases in phosphorylation of MAPK and Akt (MOG repartitioning-independent) were unaffected by treatment with MCD (Fig. 7B) . We conclude that two signal transduction pathways are activated by the binding of anti-MOG to its ligand, one acting through MOG in its nonraft state (i.e. MAPK and Akt) and another that requires MOG repartitioning into lipid rafts and that induces morphological alterations in OLs. DISCUSSION An important aspect of the pathogenesis of demyelination in multiple sclerosis involves brain inflammation mediated by T cells, leading to local activation of microglia and impairment of the integrity of the blood brain barrier. In addition, there is increasing evidence that anti-MOG antibodies play an important role by entering the central nervous system through a compromised blood-brain barrier and destroying myelin (8 -10) . Although there is still some controversy on the specificity of the antibody response in multiple sclerosis patients, the role of anti-MOG in those patients with pattern II demyelination has been clearly demonstrated (5) . A similar pathology with severe demyelination is found in an experimental allergic encephalomyelitis in both rodents and primates upon the presen- tation of either purified MOG or anti-MOG antibody (8, (47) (48) (49) . In addition, demyelination has been produced in aggregating brain cell cultures by anti-MOG, whereas antibodies against other myelin proteins had no effect (50) .
Despite the evidence that MOG/anti-MOG interactions could be mediators of demyelination in EAE and multiple sclerosis, the mechanism is unclear. We have proposed a model in which antibody binding to MOG on the surface of OLs leads to altered signal transduction mediated by glycopshingolipid-cholesterol microdomains (lipid rafts) (14) . Specifically, we showed that complement-independent antibody cross-linking of MOG on the surface of OLs results in the rapid repartitioning of MOG into lipid rafts, leading to specific changes in the pattern of protein phosphorylation and culminating in a rapid retraction of OL processes and myelin-like membranes (14) . It is noteworthy that these changes are specific for anti-MOG; e.g. although cross-linking MAG also instigates signaling modifications, these are distinct from those observed with MOG and do not result in morphological alterations (3). Further, whereas both anti-MOG and anti-MAG antibodies are detected among the abundance of autoantibody responses in multiple sclerosis, only anti-MOG antibodies appear to be pathogenic in this disease (5, 51, 52) .
In the present study, we have obtained important insights into the anti-MOG⅐MOG-mediated mechanism by identifying a specific set of proteins that change their phosphorylation state upon MOG cross-linking and placing them in a functional context. These data are accompanied by analyses of signal trans- duction pathways that are likely to be involved and the demonstration that OL cell death does not occur.
On the basis of these results, we propose the following model (Fig. 8) . Upon OL treatment with anti-MOG antibody alone, MAPK and Akt pathways are activated, and Ca 2ϩ levels increase. These signaling modifications appear to be lipid raftindependent, since neither MOG, MAPK, or Akt are found in these microdomains under these conditions. Further, since the Akt, and probably MAPK, pathways promote survival of OLs (25, 26) , these changes may have implications in the normal physiology of the cell, in which stimulation of MOG with a hypothetical ligand may support survival of OLs. Upon further cross-linking the MOG⅐anti-MOG complexes by anti-IgG antibodies, MOG becomes repartitioned into detergent-insoluble complexes, at least half of which exhibit characteristics of lipid rafts. According to current models, lipid rafts provide a specialized environment for novel molecular interactions that can activate signal transduction pathways (11). Here we demonstrate the lipid raft-dependent activation of two physiological events. One, a stress-related pathway, is implicated by virtue of the phosphorylation of ␣-enolase, HSP74, and EF-2 and increased levels of HSC70. Second, a reduction of cytoskeletal integrity is indicated by inactivation of Fyn that can promote dephosphorylation of ␤-tubulin and the phosphorylation of CRMP-2 and annexin vi, leading to retraction of cell processes and loss of membranes. In addition, the observed inactivation of G␤ may alter the ␤␥-mediated regulation of calcium channels (27) and survival pathways (53) .
Among the phosphorylation changes affecting cytoskeletal integrity, the activation of CRMP-2 appears to be of particular importance, since a substantial attenuation of the OL morphological damage is achieved by preventing Rho kinase-mediated CRMP-2 phosphorylation. These results agree with previous observations showing that Rho kinase activation inhibits process extension of OLs (54) . Moreover, Fyn kinase down-regulates Rho kinase activity during OL differentiation (55), suggesting that the activation of CRMP-2 through Rho kinase shown in our model may be a downstream effect of Fyn inactivation. We conclude that the rearrangement of the OL cytoskeleton is a key event following MOG cross-linking, leading to severe morphological, and thus functional, implications. In principle, a reversion of harmful effects of MOG cross-linking could be effected by preventing these cytoskeletal changes, suggesting a potential target for therapeutic intervention in multiple sclerosis.
Since our model proposes that a secondary cross-linking antibody is required in order to activate demyelinating signaling, the question arises as to the identity of a binding partner for anti-MOG that could be playing that role in vivo. For example, macrophages and complement are logical candidates for mimicking the effect of the secondary cross-linking antibody by virtue of their ability to bind IgG molecules (56) . Alternatively, MOG binds the complement component C1q (57) , although recent structural data on MOG suggests that the proposed C1q site is oriented toward the membrane surface, adopting a conformation that would prevent the binding of C1q in vivo (58) . Nevertheless, in our model, once anti-MOG antibody binds to the OL surface, C1q could bind to the Fc region of anti-MOG and possibly mimic the effects that we observe using a crosslinking secondary antibody. A similar effect could be triggered upon binding of Fc receptors from macrophages. In addition, the simultaneous presence of polyclonal anti-MOG antibodies that recognize different epitopes of MOG in multiple sclerosis patients could be sufficient to cross-link MOG and initiate a lipid-raft-mediated demyelinating signaling, in this case eliminating the requirement for a secondary cross-linking molecule.
The further elucidation of both physiologic and pathological induced MOG/anti-MOG binding partners offers exciting potential for novel therapies for multiple sclerosis.
